BRCA1 and gastric cancer: Mechanistically, circAKT3 activates the PI3K/AKT signaling pathway in GC cells by sponging miR-198 to eliminate the inhibitory effect of this miRNA on its target gene PIK3R1. Activation of the PI3K/AKT pathway contributes to the upregulation of the DNA repair molecule BRCA1, leading to resistance to cisplatin-based chemotherapy.CircAKT3 affected the DNA damage response (DDR) in GC cells, suggested that circAKT3 may enhance cisplatin resistance through the PI3K/AKT pathway and DDdR mechanism in GC cells (151).